Patient demographics, diagnosis, and clinical course
| No. | Age (yr) | Sex | Initial Pathology (date) | Follow-Up Intervalsa (mo) | Diagnosisb | Reference Standard |
|---|---|---|---|---|---|---|
| 1 | 30 | F | GBM, May 2003 | 6 and 9 | RT | Biopsy |
| 2 | 30 | M | Oligodendroglioma, March 2008 | 4 and 8 | RT | Clinical/MRI follow-up |
| 3 | 59 | F | Oligodendroglioma, May 2005 | 24 and 26 | SD | Clinical/MRI follow-up |
| 4 | 63 | F | GBM, February 2008 | 10 and 12 | SD | Clinical/MRI follow-up |
| 5 | 61 | M | GBM, June 2008 | 2 and 4 | RT | Clinical/MRI follow-up |
| 6 | 57 | M | Astrocytoma,c August 2008 | 1 and 3 | RT | Clinical/MRI follow-up |
| 7 | 55 | M | GBM, May 2008 | 7 and 9 | SD | Clinical/MRI follow-up |
| 8 | 44 | F | Oligodendroglioma, 1996 | 6 and 8 | RT | Biopsy |
| 9 | 29 | F | GBM, October 2006 | 6 and 8 | RT | Biopsy |
| 10 | 48 | F | GBM, September 2005 | 4 and 5 | SDd | Clinical/MRI follow-up |
| 11 | 92 | F | GBM, November 2007 | 3 and 7 | RT Pseudo | Deceased |
| 12 | 36 | M | GBM, November 2007 | 4 and 5 | SDd | Clinical/MRI follow-up |
| 13 | 53 | F | Astrocytoma,c May 2008 | 6 and 10 | SD | Clinical/MRI follow-up |
| 14 | 62 | M | Astrocytoma,c October 2008 | 6 and 8 | RT | Biopsy |
| 15 | 60 | M | GBM | 4 and 7 | RT | Biopsy |
| 16 | 42 | F | GBM, April 2009 | 1 and 3 | RT | Clinical/MRI follow-up |
| 17 | 71 | M | GBM, October 2008 | 1 and 3 | RT | Clinical/MRI follow-up |
a Scanning follow-up intervals after treatment for new enhancing lesions.
b Most probable diagnosis of new lesions: GBM, RT, SD (most likely radiation-chemotherapy change).
c Anaplastic astrocytoma.
d Patients underwent additional MR imaging showing no change in radiologic features or change in clinical status.